Literature DB >> 9310481

CD34 expression patterns during early mouse development are related to modes of blood vessel formation and reveal additional sites of hematopoiesis.

H B Wood1, G May, L Healy, T Enver, G M Morriss-Kay.   

Abstract

CD34 is a cell surface glycoprotein that is selectively expressed within the human hematopoietic system on stem and progenitor cells, and in early blood vessels. To elucidate its functions during early blood vessel formation and hematopoiesis, we analyzed the expression patterns, in day 8 to day 10 mouse embryos, of CD34 RNA by in situ hybridization and protein by immunohistochemistry using the monclonal antibody RAM 34. Levels of expression in embryonic blood vessels were correlated with the mode of vessel formation, being high in pre-endothelial cells and in vessels forming by vasculogenesis (particularly the dorsal aortae) or angiogenesis, but low in vessels forming by coalescence (the cardinal veins). CD34+ erythroid cells, presumably of yolk sac origin, were present in the liver of day 10 embryos; at the same stage, putative definitive hematopoietic cells, strongly CD34+, were present in the para-aortic mesenchyme. Possible sites of hemangioblastic differentiation were detected in the form of CD34+ endothelium-attached hematopoietic cells in the dorsal aorta and in two previously unreported locations, the proximal umbilical and vitelline arteries. These observations suggest functions for CD34 in relation to specific modes of blood vessel formation, and a hemangioblastic role in both embryonic and extraembryonic sites.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9310481

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  45 in total

1.  Definitive hematopoietic stem cells first develop within the major arterial regions of the mouse embryo.

Authors:  M F de Bruijn; N A Speck; M C Peeters; E Dzierzak
Journal:  EMBO J       Date:  2000-06-01       Impact factor: 11.598

2.  Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization.

Authors:  T Murohara; H Ikeda; J Duan; S Shintani; K i Sasaki; H Eguchi; I Onitsuka; K Matsui; T Imaizumi
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

Review 3.  CD34-positive stem cells: in the treatment of heart and vascular disease in human beings.

Authors:  Alexander R Mackie; Douglas W Losordo
Journal:  Tex Heart Inst J       Date:  2011

4.  The scl +18/19 stem cell enhancer is not required for hematopoiesis: identification of a 5' bifunctional hematopoietic-endothelial enhancer bound by Fli-1 and Elf-1.

Authors:  Berthold Göttgens; Cyril Broccardo; Maria-Jose Sanchez; Sophie Deveaux; George Murphy; Joachim R Göthert; Ekaterini Kotsopoulou; Sarah Kinston; Liz Delaney; Sandie Piltz; Linda M Barton; Kathy Knezevic; Wendy N Erber; C Glenn Begley; Jonathan Frampton; Anthony R Green
Journal:  Mol Cell Biol       Date:  2004-03       Impact factor: 4.272

Review 5.  RUNX1 and the endothelial origin of blood.

Authors:  Long Gao; Joanna Tober; Peng Gao; Changya Chen; Kai Tan; Nancy A Speck
Journal:  Exp Hematol       Date:  2018-10-31       Impact factor: 3.084

6.  Characterization of purified intraembryonic hematopoietic stem cells as a tool to define their site of origin.

Authors:  Julien Y Bertrand; Sébastien Giroux; Rachel Golub; Michèle Klaine; Abdelali Jalil; Laurent Boucontet; Isabelle Godin; Ana Cumano
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-27       Impact factor: 11.205

Review 7.  Beyond mere markers: functions for CD34 family of sialomucins in hematopoiesis.

Authors:  Sebastian George Barton Furness; Kelly McNagny
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

8.  Immunotargeting and cloning of two CD34 variants exhibiting restricted expression in adult rat endothelia in vivo.

Authors:  Jacqueline E Testa; Adrian Chrastina; Phil Oh; Yan Li; Halina Witkiewicz; Malgorzata Czarny; Tim Buss; Jan E Schnitzer
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-05-22       Impact factor: 5.464

9.  ACE2/Ang-(1-7)/Mas axis stimulates vascular repair-relevant functions of CD34+ cells.

Authors:  Neha Singh; Shrinidh Joshi; Lirong Guo; Matthew B Baker; Yan Li; Ronald K Castellano; Mohan K Raizada; Yagna P R Jarajapu
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-09-18       Impact factor: 4.733

10.  Human vascular progenitor cells derived from renal arteries are endothelial-like and assist in the repair of injured renal capillary networks.

Authors:  Paul Pang; Molly Abbott; Steven L Chang; Malyun Abdi; Nikita Chauhan; Murti Mistri; Joshua Ghofrani; Quynh-Anh Fucci; Colleen Walker; Corey Leonardi; Samuel Grady; Arvin Halim; Ryan Hoffman; Tzongshi Lu; Huixia Cao; Stefan G Tullius; Sayeed Malek; Sanjaya Kumar; Graeme Steele; Adam Kibel; Benjamin S Freedman; Sushrut S Waikar; Andrew M Siedlecki
Journal:  Kidney Int       Date:  2016-09-29       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.